A small-molecule antagonist of HIF2α is efficacious in preclinical models of renal cell carcinoma - Wallace, E M; Rizzi, J P; Han, G; Wehn, P M; Cao, Z; Du, X; Cheng, T; Czerwinski, R M; Dixon, D D; Goggin, B S; Grina, J A; Halfmann, M M; Maddie, M A; Olive, S R; Schlachter, S T; Tan, H; Wang, B; Wang, K; Xie, S; Xu, R; Yang, H; Josey, J A (Cancer Res, 2016)